Stocktoria
ArriVent BioPharma, Inc. AVBP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-01-26
ArriVent BioPharma, Inc. statistics & valuation
Market cap$1.6B
P / B5.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -49.9% | -29.3% | -42.5% |
| Return on equity | -54.1% | -31.2% | 45.3% |
| Current ratio | 12.83 | 13.14 | 13.76 |
Source: SEC EDGAR filings · CIK 0001868279 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.